Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
This review emphasizes the high prevalence of chronic kidney disease among hypertensive patients and underscores the importance of early screening and nephroprotective strategies to prevent cardiovascular complications.
A review deals with the problem of chronic kidney disease (CKD) from the position of a physician and cardiologist. The epidemiology of the disease was discussed both abroad and in Russia, including the most up-to-date data. In Russia CKD markers were detected in 49.4% of hypertensives. Authors describe risk factors and mechanisms of CKD at the most important pathogenetic conditions: hypertension, diabetes and obesity. The current classification and methods for calculating the glomerular filtration rate are given. The review disclose a paradigm of the renal continuum and its relation to cardiovascular diseases. It is well known fact that the final causes of the death of patients with CKD, as a rule, are cardiovascular complications. Based on the literature data, the necessity and expediency of screening for renal dysfunction is justified. In the example of use of an angiotensin receptor blocker II - irbesartan nephroprotective demonstrated possibilities of intervention in patients with renal dysfunction of varying severity.
No takes yet. Share an insight, caveat, or question.
Подзолков et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: